National Institutes of Health to Grant Exclusive Patent License to Beacon Biomedical for Cancer Detection Tests

Summary

The National Institutes of Health is issuing a notice of intent to grant an exclusive patent license to Beacon Biomedical for the development of point-of-care tests and kits for colon, breast, and lung cancer detection, as required by US patent laws.